Risk prediction models for antineoplastic-associated cardiotoxicity in treatment of breast cancer: A systematic review.

Rodriguez, Ryan; Joseph, Honey; Macrito, Rosa; Lee, Todd A; Sweiss, Karen

Rodriguez, Ryan; Joseph, Honey; Macrito, Rosa; Lee, Todd A; Sweiss, Karen.

Afiliação

Rodriguez R; Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA.
Joseph H; Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA.
Macrito R; Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA.
Lee TA; Department of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA.
Sweiss K; Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA.

Am J Health Syst Pharm ; 80(19): 1315-1325, 2023 09 22.

Article em En | MEDLINE | ID: mdl-37368407

Assuntos

Antineoplásicos; Neoplasias da Mama; Humanos; Feminino; Cardiotoxicidade/etiologia; Cardiotoxicidade/complicações; Neoplasias da Mama/tratamento farmacológico; Antineoplásicos/efeitos adversos; Trastuzumab; Antraciclinas/efeitos adversos

Palavras-chave

anthracycline; breast cancer; cardiotoxicity; risk prediction; systematic review; trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google